Modulation of serine/threonine-protein phosphatase 1 (PP1) complexes: a promising approach in cancer treatment
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Abstract
Cancer is the second leading cause of death worldwide. Despite the numerous therapeutic options available, tumor heterogeneity and chemoresistance have limited their success and the development of an effective anticancer therapy remains a major challenge in oncology research. The serine/threonine-protein phosphatase 1 (PP1) and its complexes have been recognized as potential drug targets. Although research on the modulation of PP1 complexes is currently at an early stage, there is an immense potential. Chemically diverse compounds have been developed to disrupt or stabilize different PP1 complexes in various cancer types with the objective to inhibit disease progression. Beneficial results obtained in vitro now require further pre-clinical and clinical validation. In conclusion, the modulation of PP1 complexes seems to be a promising, albeit challenging, therapeutic strategy for cancer.Citation
Matos, B., Howl, J., Jerónimo, C. and Fardilha, M. (2021) Modulation of serine/threonine-protein phosphatase 1 (PP1) complexes: a promising approach in cancer treatment. Drug Discovery Today, 26(11), pp. 2680-2698. https://doi.org/10.1016/j.drudis.2021.08.001Publisher
ElsevierJournal
Drug Discovery TodayType
Journal articleLanguage
enDescription
This is an accepted manuscript of an article published by Elsevier in Drug Discovery Today, available online at: https://doi.org/10.1016/j.drudis.2021.08.001 The accepted version of the publication may differ from the final published version.ISSN
1359-6446Sponsors
Portuguese Foundation for Science and Technology (FCT), European Union, QREN, FEDER and COMPETE funded iBiMED (UID/BIM/04501/2020, POCI-01-0145-FEDER-007628 and UID/BIM/04501/2019) and an individual scholarship from BM (SFRH/BD/146032/2019).ae974a485f413a2113503eed53cd6c53
10.1016/j.drudis.2021.08.001
Scopus Count
Collections
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/